Antibody-Directed Enzyme Prodrug Therapy

This publication has 60 references indexed in Scilit:

• Application of monoclonal antibodies against cytosine deaminase for the in vivo clearance of a cytosine deaminase immunoconjugate
  Bioconjugate Chemistry, 1993
• Tumour necrosis factor increases tumour uptake of Co-administered antibody-carboxypeptidase G2 conjugate
  European Journal Of Cancer, 1993
• Analysis of a conjugate between anti-carcinoembryonic antigen monoclonal antibody and alkaline phosphatase for specific activation of the prodrug etoposide phosphate
  Cancer Immunology, Immunotherapy, 1992
• Preparation and characterization of a .beta.-lactamase-Fab' conjugate for the site-specific activation of oncolytic agents
  Bioconjugate Chemistry, 1992
• A novel targeted delivery system utilizing a cephalosporin-oncolytic prodrug activated by an antibody β-lactamase conjugate for the treatment of cancer
  Bioorganic & Medicinal Chemistry Letters, 1991
• Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compounds
  European Journal of Cancer and Clinical Oncology, 1991
• Second generation analogs of etoposide and mitomycin C
  Cancer Treatment Reviews, 1990
• Antibody-penicillin-V-amidase conjugates kill antigen-positive tumor cells when combined with doxorubicin phenoxyacetamide
  Cancer Immunology, Immunotherapy, 1990
• Cytotoxicity of glucose oxidase conjugated with antibodies to target cells: killing efficiency depends on the conjugate internalization
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1990
• Protection of cultured endothelial cells from hydrogen peroxide-induced injury by antibody-conjugated catalase
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1987